Additional file 1: Table S1. Validating the prediction power of the gene signature for OS in the combined GEO dataset by re-sampling analysis
Additional file 14: Figure S12. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 13: Figure S11. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 5. Multidimensional scaling analysis of the 45-gene signature and disease-free survi...
Additional file 2: Table S2. Validating the prediction power of the gene signature for DSF in the co...
Abstract Background The high mortality of patients with non-small cell lung cancer (NSCLC) emphasize...
Additional file 6: Figure S4. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 1. Abbreviations and number of tumor and non-tumor samples in TCGA cancers
Additional file 5: Figure S3. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 7: Figure S5. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 2: Table S2. The coefficient value of 30 immune related risk genes
Additional file 4: Figure S2. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 3: Figure S1. The Kaplan–Meier survival analysis for the 30 immune related genes in ...
Additional file 15. Correlation of risk scores, as determined using the 8-gene signature, and hypoxi...
Additional file 11. Kaplan-Meier plot of disease-free survival in HCC patients from the GSE14520 coh...
Additional file 16. Kaplan-Meier plot depicting combined relation of CDKN2A mutation status with the...
Additional file 14: Figure S12. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 13: Figure S11. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 5. Multidimensional scaling analysis of the 45-gene signature and disease-free survi...
Additional file 2: Table S2. Validating the prediction power of the gene signature for DSF in the co...
Abstract Background The high mortality of patients with non-small cell lung cancer (NSCLC) emphasize...
Additional file 6: Figure S4. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 1. Abbreviations and number of tumor and non-tumor samples in TCGA cancers
Additional file 5: Figure S3. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 7: Figure S5. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 2: Table S2. The coefficient value of 30 immune related risk genes
Additional file 4: Figure S2. The KaplanâMeier survival analysis for the 30 immune related genes i...
Additional file 3: Figure S1. The Kaplan–Meier survival analysis for the 30 immune related genes in ...
Additional file 15. Correlation of risk scores, as determined using the 8-gene signature, and hypoxi...
Additional file 11. Kaplan-Meier plot of disease-free survival in HCC patients from the GSE14520 coh...
Additional file 16. Kaplan-Meier plot depicting combined relation of CDKN2A mutation status with the...
Additional file 14: Figure S12. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 13: Figure S11. Correlation of the risk signature with clinicopathologic factors in ...
Additional file 5. Multidimensional scaling analysis of the 45-gene signature and disease-free survi...
DOI
Add to ORKG